In the top M&A, Baxter International Inc. signed a definitive agreement in which investment firm Carlyle will acquire its kidney care segment, to be named Vantive, for $3.8bn. Vantive offers products and services for peritoneal dialysis, hemodialysis and organ support therapies, including continuous renal replacement therapy. Vantive's brands include Sharesource (a remote patient management system), Homechoice Claria (an automated peritoneal dialysis system), and Amia (an automated peritoneal dialysis system).
Financing reached $4.1bn in biopharma, $419m in device, and $637m in diagnostics.